Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia

MeSH terms

• Adolescent
• Adult
• Antineoplastic Agents / administration & dosage*
• Benzamides
• Female
• Graft vs Host Disease / drug therapy*
• Graft vs Leukemia Effect / drug effects*
• Humans
• Imatinib Mesylate
• Incidence
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
• Male
• Middle Aged
• Philadelphia Chromosome
• Piperazines / administration & dosage*
• Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
• Pyrimidines / administration & dosage*
• Stem Cell Transplantation*
• Transplantation, Homologous
• Treatment Outcome
• Young Adult